Skip to main content
Premium Trial:

Request an Annual Quote

Polyplus Raises $3.3M in Private Financing

Premium

Polyplus Transfection said this week that it has raised €2.5 million ($3.3 million) through a round of private financing.

The round brings in new investors Alsace Inter Regio Fonds d’Investissement and Sudinnova, while existing investors CIC Vizille Capital Innovation and CIC Finance also participated.

The company said it will use the funds to advance new siRNA delivery compounds and add 10 new researchers and lab technicians, which would bring its total headcount to 40.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.